Status:
COMPLETED
Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome
Lead Sponsor:
GlaxoSmithKline
Conditions:
Irritable Colon
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to see if GW876008 in Irritable Bowel Syndrome patients will reverse stress-induced hypersensitivity, by looking at thresholds for perception and pain.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Must have irritable bowel syndrome.
- Exclusion criteria:
- Subjects who have been taking any medication for the treatment of irritable bowel syndrome within 6 months prior to the start of the study.
Exclusion
Key Trial Info
Start Date :
December 8 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2007
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00385099
Start Date
December 8 2006
End Date
October 15 2007
Last Update
August 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
London, United Kingdom, NW1 2BU